A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and Filgrastim in high-risk breast cancer patients

Blood

Volumn 93, Issue 8, 1999, Pages 2491-2501

  Shpall, Elizabeth J ^a   Wheeler, Catherine A ^b   Turner, Stewart A ^b   Yanovich, Saul ^b   Brown, Randy A ^b   Pecora, Andrew L ^b   Shea, Thomas C ^b   Mangan, Kenneth F ^b   Williams, Stephanie F ^b   LeMaistre, C Fred ^b   Long, Gwynn D ^b   Jones, Roy ^b   Davis, Mark W ^b   Murphy Filkins, Robyn ^b   Parker, William R L ^b   Glaspy, John A ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HEMATOPOIETIC CELL; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TARGET CELL;

ADULT; ANTIGENS, CD; ANTIGENS, CD34; BREAST NEOPLASMS; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MIDDLE AGED; NEOPLASM STAGING; STEM CELL FACTOR;

EID: 0033560848     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilized by Filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992
2. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Zander A, Barge A, Borkett K: Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:353, 1996
3. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner CD: Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 13:2547, 1995
4. Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, Chauncey T, Storb R, Buckner CD: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825, 1994
5. + cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematol 5:213, 1996
6. Demirer T, Buckner CD, Bensinger WI: Optimization of peripheral blood stem cell mobilization. Stem Cells 14:106, 1996
7. Tricot G, Jagannath S, Vesole DH, Crowley J, Barlogie B: Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:558, 1995
8. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961, 1995
9. + cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 19:303, 1997
10. + cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. J Clin Oncol 13:1922, 1995
11. Pettengell R, Morgenstern GR, Woll PJ, Chang J, Rowlands M, Young R, Radford JA, Scarffe HJ, Testa NG, Crowther D: Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82:3770, 1993
12. Knudsen LM, Gaarsdal E, Jensen L, Nielsen KJ, Nikolaisen K, Johnsen HE: Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells. J Hemathother 5:399, 1996
13. Glaspy JA, Shpall EJ, LeMaistre CF, Briddell RA, Menchaca DM, Turner SA, Lill M, Chap L, Jones R, Wiers MD, Sheridan W, McNiece IK: Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood 90:2939, 1997
14. Moskowitz CH, Stiff P, Gordon MS, McNiece I, Ho AD, Costa JJ, Broun ER, Bayer RA, Wyres M, Hill J, Jelaca-Maxwell K, Nichols CR, Brown SL, Nimer SD, Gabrilove J: Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients - Results of a phase I/II trial. Blood 89:3136, 1997
15. Weaver A, Ryder D, Crowther D, Dexter TM, Testa NG: Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomized to receive increasing doses of stem-cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor. Blood 88:3323, 1996
16. Begley CG, Basser R, Mansfield R, Thomson B, Parker WR, Layton J, To B, Cebon J, Sheridan WP, Fox RM, Green MD: Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans. Blood 90:3378, 1997
17. Rasko JEJ, Basser RL, Boyd J, Mansfield R, O'Malley CJ, Hussein S, Berndt MC, Clarke K, O'Byrne J, Sheridan WP, Brigg AP, Begley CG: Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. Br J Haematol 97:871, 1997
18. Basser RL, Rasko JEJ, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG: Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 89:3118, 1997
19. Lebsack ME, McKenna HJ, Hoek JA, Hanna R, Feng A, Marashovsky E, Hayes FA: Safety of FLT3 ligand in healthy volunteers. Blood 90:170a, 1997 (abstr, suppl 1)
20. DiPersio JF, Abboud CN, Schuster MW, Winter JN, Collins DM, Santos VR, Baum CM: Phase II study of mobilization of PBSC by administration of daniplestim (SC-55494) and G-CSF in patients with breast cancer of lymphoma. Proc Am Soc Clin Oncol 16:87a, 1997 (abstr)
21. Morstyn G, Brown S, Gordon M, Crawford J, Demetri G, Rich W, McGuire B, Foote MA, McNiece I: Stem cell factor is a potent synergistic factor in hematopoiesis. Oncology 51:205, 1994
22. Glaspy J: Clinical applications of stem cell factor. Curr Opin Hematol 3:223, 1996
23. Broudy V: Stem cell factor and hematopoiesis. Blood 90:1345, 1997
24. Briddell RA, Hartley CA, Smith KA, McNiece IK: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720, 1993
25. McNiece IK, Briddell RA, Hartley CA, Smith KA, Andrews RG: Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells. Stem Cells 11:36, 1993
26. Yan XQ, Briddell R, Hartley C, Stoney G, Samal B, McNiece I: Mobilization of long-term hematopoietic reconstituting cells in mice by the combination of stem cell factor plus granulocyte colony-stimulating factor. Blood 84:795, 1994
27. de Revel T, Appelbaum FR, Storb R, Schuening F, Nash R, Deeg J, McNiece I, Andrews R, Graham T: Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83:3795, 1994
28. Andrews RG, Briddell RA, Knitter GH, Opie T, Bronsden M, Myerson DH, Appelbaum FR, McNiece IK: In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons. Enhanced circulation of progenitor cells. Blood 84:800, 1994
29. Andrews RG, Briddell RA, Knitter GH, Rowley SD, Appelbaum FR, McNiece IK: Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor. Blood 85:15, 1995
30. + hematopoietic stem cells. J Hematother 5:227, 1996
31. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473, 1992
32. Williams A: EuroQoL - A new facility for the measurement of health-related quality of life. Health Policy 16:199, 1990
33. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K, Lloyd S, Purl S, Blendowski C, Goodman M, Barnicle M, Stewart I, McHale M, Bonomi P, Kaplan E, Taylor S IV, Thomas CR Jr, Harris J: The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 11:570, 1993
34. McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, Hurd DD: Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 19:357, 1997
35. Matthews JNS, Altman D, Campbell MJ, Royston P: Analysis of serial measurements in medical research. Br Med J 300:230, 1990
36. Orenstein D, Kaplan R: Measuring the quality of well-being in cystic fibrosis and lung transplantation: The importance of the area under the curve. Chest 100:1016, 1991
37. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Glaspy J: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164, 1991
38. Ravagriani F, Siena S, Bregni M, Sciorelli G, Gianni AM, Pellegris G: Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur J Cancer 26:562, 1990
39. + cells reinfused is the only factor predicting both granulocyte and platelet recovery. J Hematother 5:663, 1996
40. Glaspy JA, Snyder C, Lu J, Erder MH: A resource-based cost analysis of G-CSF-primed peripheral blood progenitor cell procurement (PBPCP). Proc Am Soc Clin Oncol 16:412a, 1997 (abstr)
41. Stiff P, Gingrich R, Luger S, Brown RA, LeMaistre CF, Perry J, Schenkein D, List A, Mason JR, Bensinger W, Wheeler CA, Freter C, Murphy-Filkins R, Wyres M, Parker W, Emmanouilides C: Improved PBPC collection using STEMGEN (stem cell factor, SCF) and Filgrastim (G-CSF) compared to G-CSF alone in heavily pretreated lymphoma (NHL) and Hodgkin's disease (HD) patients (pts). Blood 90:591a, 1997 (abstr, suppl 1)
42. Tricot G, Jagannath S, Desikan KR, Siegel D, Munshi N, Olson E, Wyres M, Parker W, Barlogie B: Superior mobilization of peripheral blood progenitor cells (PBPC) with r-metHuSCF (SCF) and r-metHuG-CSF (Filgrastim) in heavily pretreated multiple myeloma (MM) patients. Blood 88:388a, 1996 (abstr, suppl 1)
43. Sheridan WP, Begley CG, To LB, Grigg A, Szer J, Maher D, Green MD, Rowlings PA, McGrath KM, Cebon J, Dyson P, Watson D, Bayly J, De Luca E, Tomita D, Hoffman E, Morstyn G, Juttner CA, Fox RM: Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 14:105, 1994
44. Leyvraz S, Ketterer N, Perey L, Bauer J, Vuichard P, Grob JP, Schneider P, von Fliedner V, Lejeune F, Bachmann F: Intensification of chemotherapy for the treatment of solid tumours: Feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony-stimulating factor. Br J Cancer 72:178, 1995
45. Weaver CH, Birch R, Greco FA, Schwartzberg L, McAneny B, Moore M, Oviatt D, Redmond J, George C, Alberico T, Johnson P, Buckner CD: Mobilization and harvesting of peripheral blood stem cells: Randomized evaluations of different doses of filgrastim. Br J Haematol 100:338, 1998
46. Franklin WA, Pflaumer SM, Jones RB, Hami L, Garza-Williams S, Turner SA, Davis MW, Martinez C, Bearman S, Cagnoni P, Ross M, Shpall EJ: The addition of stem cell factor (SCF) to filgrastim (r-metHuG-CSF) for the mobilization of PBPC does not enhance mobilization of tumor cells into the peripheral blood of breast cancer patients. Proc Am Soc ClinOncol 16:118a, 1997 (abstr)
47. Morgan M, MaWhinney S, Wang JK, Shpall FJ, Curiel T: Reconstitution of humoral, cellular and natural immunity after transplantation of autologous hematopoietic progenitor cells to support high-dose chemotherapy. Blood 90:100a, 1997 (abstr, suppl 1)